Chelsea Morroni
Overview
Explore the profile of Chelsea Morroni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
1678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cavagnis S, Ryan R, Mussa A, Hargreaves J, Tucker J, Morroni C
Front Glob Womens Health
. 2025 Jan;
5():1235475.
PMID: 39776787
During the COVID-19 pandemic, family planning services over the world have been disrupted. There are still uncertainties about the impact on access to contraception, particularly among marginalised populations. This study...
2.
Babalola C, Mussa A, Masire D, Morroni C, Klausner J
BMC Glob Public Health
. 2024 Dec;
2(1):47.
PMID: 39681949
No abstract available.
3.
Hunter E, Fine E, Black K, Henriks J, Tofail F, Morroni C, et al.
Bull World Health Organ
. 2024 Nov;
102(12):861-872.
PMID: 39611192
Objective: To refine a standard questionnaire on sexual practices, experiences and health-related outcomes to improve its cross-cultural applicability and interpretability. We aimed to explore participants' willingness and ability to answer...
4.
Mussa A, Wynn A, Ryan R, Babalola C, Hansman E, Simon S, et al.
Sex Transm Infect
. 2024 Oct;
PMID: 39366745
Objectives: and are common sexually transmitted infections (STIs). Untreated infection in pregnancy can result in adverse neonatal outcomes, including vertical transmission. Screening for these infections is not routine in low-...
5.
van der Veer C, Kondoni C, Kuyere A, Mtonga F, Nyasulu V, Shaba G, et al.
Sex Transm Infect
. 2024 Jul;
100(8):517-523.
PMID: 39043612
Background: There are limited data on the epidemiology of sexually transmitted infections (STI) and their contribution to adverse birth outcomes (ABO) in sub-Saharan Africa (SSA). We performed a case-control study...
6.
Todd C, Lorenzetti L, Mussa A, Ridgeway K, Morroni C, Nanda K
Contraception
. 2024 May;
138:110490.
PMID: 38762199
Objective: To summarize and update information regarding drug-drug interactions (DDIs) between antiretrovirals (ARVs) and hormonal contraceptives (HCs). Study Design: Systematic review. Results: We included 49 articles, with clinical, ARV, or...
7.
Tucker J, Dziva Chikwari C, Tang W, Jarolimova J, Gravett R, Goense C, et al.
Sex Transm Dis
. 2024 Mar;
51(7):e31-e35.
PMID: 38465975
Background: Designathons can be used to enhance public health training and spur innovation. A designathon is a 3-stage participatory activity that includes preparation, intensive collaboration, and follow-up activities. We organized...
8.
Hofmeyr G, Singata-Madliki M, Batting J, Balakrishna Y, Morroni C
BMC Womens Health
. 2024 Mar;
24(1):167.
PMID: 38459552
Background: Robust information on relative effects of hormonal contraceptives on endogenous androgens is important for understanding beneficial and adverse effects, method choice and development of new methods. Methods: In this...
9.
Wynn A, Mussa A, Ryan R, Babalola C, Hansman E, Ramontshonyana K, et al.
BJOG
. 2024 Feb;
131(9):1259-1269.
PMID: 38351649
Objective: To evaluate the impact of screening and treating asymptomatic pregnant women for Chlamydia (C.) trachomatis and Neisseria (N.) gonorrhoeae infections on the frequency of preterm birth or low birthweight...
10.
Hansman E, Mussa A, Ryan R, Babalola C, Ramontshonyana K, Tamuthiba L, et al.
Sex Transm Dis
. 2024 Feb;
51(5):331-336.
PMID: 38301627
Background: Partner notification and treatment for sexually transmitted infections are critical to prevent reinfection and reduce transmission. However, partner treatment rates are low globally. Expedited partner therapy (EPT), in which...